MoneyWorks4Me

Net sales declined -8.71%  to  Rs. 1163.90 million from Rs. 1275.00 millions.Net profit stood at Rs. 632.40  millions  compared to Rs. 545.50 millions in the corresponding previous quarter,high by 15.93%.The company reported a good operating profit of 810.80 millions compared to 756.40 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1163.90 1275.00 -8.71 1163.90 1275.00 -8.71 5280.60 4826.80 9.40
Other Income 349.70 193.30 80.91 349.70 193.30 80.91 565.50 186.20 203.71
PBIDT 810.80 756.40 7.19 810.80 756.40 7.19 2761.70 2325.50 18.76
Interest 0.10 0.30 -66.67 0.10 0.30 -66.67 0.90 1.70 -47.06
PBDT 810.70 756.10 7.22 810.70 756.10 7.22 2760.80 2323.80 18.81
Depreciation 63.70 62.00 2.74 63.70 62.00 2.74 257.70 224.40 14.84
PBT 747.00 694.10 7.62 747.00 694.10 7.62 2503.10 2099.40 19.23
TAX 114.60 148.60 -22.88 114.60 148.60 -22.88 624.40 537.10 16.25
Deferred Tax -28.00 2.30 -1317.39 -28.00 2.30 -1317.39 8.20 -11.70 -170.09
PAT 632.40 545.50 15.93 632.40 545.50 15.93 1878.70 1562.30 20.25
Equity 151.60 151.30 0.20 151.60 151.30 0.20 151.60 151.30 0.20
PBIDTM(%) 69.66 59.33 17.42 69.66 59.33 17.42 52.30 48.18 8.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..